Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141063 |
| CAS No | NA |
| Mol.F. | C16H14N6O8S2 |
| Mol.Wt. | 482.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141064 |
| CAS No | NA |
| Mol.F. | C39H45F2N3O6Si2 |
| Mol.Wt. | 746.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141065 |
| CAS No | NA |
| Mol.F. | C33H29F2N3O6 |
| Mol.Wt. | 601.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141066 |
| CAS No | NA |
| Mol.F. | C18H17FN2O4 |
| Mol.Wt. | 344.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141067 |
| CAS No | NA |
| Mol.F. | C24H22F2N2O4 |
| Mol.Wt. | 440.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141068 |
| CAS No | NA |
| Mol.F. | C35H32FN3O7 |
| Mol.Wt. | 625.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141069 |
| CAS No | NA |
| Mol.F. | C25H21FN2O5 |
| Mol.Wt. | 448.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141070 |
| CAS No | NA |
| Mol.F. | C43H43F2N3O6Si |
| Mol.Wt. | 763.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141071 |
| CAS No | NA |
| Mol.F. | C40H35F2N3O6 |
| Mol.Wt. | 691.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141072 |
| CAS No | NA |
| Mol.F. | C25H21FN2O6 |
| Mol.Wt. | 464.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141073 |
| CAS No | NA |
| Mol.F. | C24H24F2N2O4 |
| Mol.Wt. | 442.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141074 |
| CAS No | NA |
| Mol.F. | C31H30F2N2O4 |
| Mol.Wt. | 532.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141075 |
| CAS No | NA |
| Mol.F. | C24H22F2N2O5 |
| Mol.Wt. | 456.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141076 |
| CAS No | NA |
| Mol.F. | C19H20N4O6 |
| Mol.Wt. | 400.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141077 |
| CAS No | NA |
| Mol.F. | C13H13ClN4O3 |
| Mol.Wt. | 308.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141078 |
| CAS No | NA |
| Mol.F. | C13H15ClN4O |
| Mol.Wt. | 278.7 |
| INV STATUS | CUSTOM SYNTHESIS |